Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06218082

Vitiligo Registry for Adults and Children in the UK

Sponsor: The Royal Wolverhampton Hospitals NHS Trust

View on ClinicalTrials.gov

Summary

Vitiligo is the most common depigmentation disorder affecting around 1% of the population worldwide. Fifty two percent of patients develop vitiligo before the age of 20 and around 80% develop vitiligo before the age of 30 years old.1 Vitiligo often presents in childhood and tends to be a lifelong disease, requiring prolonged courses of phototherapy. Currently no national or international registry for patients with vitiligo exists. Individual dermatologists maintain a database of such patients, however no coordinated efforts have been made to combine these individual registries into a broader national registry. Finally, recently published British Association of Dermatologists (BAD) guideline for the management of vitiligo, recommended the development of a national registry for people with vitiligo undergoing systemic or light therapy to identify outcomes and safety.

Official title: Vitiligo Registry for Adults and Children in the UK (VIRTUAL-UK)

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

30

Start Date

2026-05-15

Completion Date

2030-02

Last Updated

2026-04-09

Healthy Volunteers

No

Locations (1)

The Royal Wolverhampton NHS Trust

Wolverhampton, United Kingdom